$0.69
7.23% yesterday
Nasdaq, Nov 15, 10:18 pm CET
ISIN
US74039M1018
Symbol
POAI

Predictive Oncology Inc Stock price

$0.69
+0.14 24.81% 1M
-1.05 60.54% 6M
-2.60 79.13% YTD
-2.48 78.34% 1Y
-22.51 97.04% 3Y
-76.21 99.11% 5Y
-47,499.31 100.00% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
-0.05 7.23%
ISIN
US74039M1018
Symbol
POAI
Sector

Key metrics

Market capitalization $4.58m
Enterprise Value $3.90m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.83
P/S ratio (TTM) P/S ratio 3.32
P/B ratio (TTM) P/B ratio 2.33
Revenue growth (TTM) Revenue growth -23.75%
Revenue (TTM) Revenue $1.38m
EBIT (operating result TTM) EBIT $-13.25m
Free Cash Flow (TTM) Free Cash Flow $-12.00m
Cash position $3.08m
EPS (TTM) EPS $-3.06
P/S forward 3.18
EV/Sales forward 2.75
Short interest 2.27%
Show more

Is Predictive Oncology Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Predictive Oncology Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Predictive Oncology Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Predictive Oncology Inc:

Buy
100%

Financial data from Predictive Oncology Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1.38 1.38
24% 24%
100%
- Direct Costs 1.31 1.31
10% 10%
95%
0.07 0.07
80% 80%
5%
- Selling and Administrative Expenses 13 13
9% 9%
927%
- Research and Development Expense - -
-
-
-13 -13
9% 9%
-922%
- Depreciation and Amortization 0.52 0.52
43% 43%
38%
EBIT (Operating Income) EBIT -13 -13
11% 11%
-960%
Net Profit -14 -14
24% 24%
-1,012%

In millions USD.

Don't miss a Thing! We will send you all news about Predictive Oncology Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Predictive Oncology Inc Stock News

Neutral
GlobeNewsWire
3 days ago
Company initiates process to explore a broad range of strategic alternatives to maximize shareholder value Company initiates process to explore a broad range of strategic alternatives to maximize shareholder value
Neutral
GlobeNewsWire
2 months ago
PITTSBURGH, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, is scheduled to deliver a virtual presentation and host investor one-on-one meetings at the H.C. Wainwright 26th Annual Global Investment Conference, which is being held September 9th through 11th in New York, NY.
Neutral
Seeking Alpha
3 months ago
Predictive Oncology Inc. (NASDAQ:POAI ) Q2 2024 Earnings Conference Call August 14, 2024 8:30 AM ET Company Participants Glenn Garmont – Investor Relations Raymond Vennare – Chairman and Chief Executive Officer Josh Blacher – Chief Financial Officer Conference Call Participants Operator Good day, and thank you for standing by. Welcome to the Predictive Oncology Second Quarter 2024 Earnings Conf...
More Predictive Oncology Inc News

Company Profile

Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Domestic, International, and Helomics. The Domestic and International segments focuses on STREAMWAY System product sales. The Helomics segment comprises of clinical testing and contract research. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.

Head office United States
CEO Raymond Vennare
Employees 34
Founded 2002
Website predictive-oncology.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today